glp 1 medications for type 2 diabetes What to Do if Your Medication Isn't Working New GLP-1 Guidelines for Type
Description
Diabetes Obes Metab 2017;19:15218.PubMed 14
I think this is an overblown concern
[21] A 2014 review found that the use of saxagliptin and alogliptin increased individuals' risk of developing heart failure, leading the FDA to add warnings to the labels of these drugs in 2016
The side effects were minor and didnt disrupt her daily life
Please contact GSK Consumer Healthcare directly for more information
